SEARCH RESULT

Total Matching Records found : 75

Govt Approves Drug Pricing Policy to Lower Cost of Drugs

-Outlook The government today cleared the National Pharmaceutical Pricing Policy that will bring 348 essential drugs under price control, leading to reduction in prices. "The National Pharmaceutical Pricing policy has been approved by the Cabinet with an objective to put in place a regulatory framework for pricing of drugs to ensure their availability at reasonable prices," an official source said. At present, the government through the National Pharmaceutical Pricing Authority (NPPA) controls prices...

More »

Pharma pricing policy to be discussed today-Sushmi Dey

-The Business Standard If the Cabinet clears the proposed policy, the Department of Pharmaceuticals would have to notify this before the SC?s next hearing on the matter on Nov 27 The Cabinet is likely to take up the proposed National Pharmaceutical Pricing Policy tomorrow, government sources said. The policy is aimed at capping the prices of 348 essential medicines at the weighted average of all drugs in a particular segment, with...

More »

Must poor fast to buy drugs: SC -Dhananjay Mahapatra

-The Times of India The Centre on Thursday promised to notify a new drug pricing mechanism for essential medicines by the end of November, but the Supreme Court said a change in policy must not force a sharp rise in drug prices to hurt an already hassled common man. Additional solicitor general Siddharth Luthra informed a bench of Justices G S Singhvi and S J Mukhopadhaya that a Cabinet note on the...

More »

Pricing of imported drugs under regulatory scanner-Khomba Singh

-The Economic Times India's drug price regulator has initiated a process to end the 16-year freedom enjoyed by foreign drug makers to fix the retail price of their imported medicines in the country. The National Pharmaceutical Pricing Authority (NPPA) has written to the Department of Pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its chairman CP Singh told ET. The amendment will allow NPPA to seek details of the methodology adopted...

More »

A pharma pricing web

-The Business Standard State must get out of insulin price-setting The National Pharmaceutical Pricing Authority, or NPPA, has turned down the request of drug companies to raise insulin prices. Domestic insulin-makers Biocon and Cadila had argued that the cost of production and packaging had become higher, and multinational corporation Eli Lilly wanted the depreciation in the rupee vis-à-vis the dollar to be factored into the price. The NPPA says it has...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close